drugset / Trial / NCT00586885

Effects of Alanine in Patients With Nonalcoholic Steatohepatitis

NCT00586885 ↗

NaSingle-groupOpen-labelTreatment

Summary

Purpose of this study is to assess the therapeutic efficacy of L-alanine in improving biological and histological findings by administrating 6-18g/day L-alanine for one year. We will also assess the safety and toxicity profile of long-term administration of L-alanine.

Timeline

Start
2004-02
Primary completion
2006-06
Completion
2006-06

Publications

  • Results Suzuki A, Charlton MR, Lymp JF, et al. A pilot study: No therapeutic effect of L-alanine in patients with nonalcoholic steatohepatitis. Food and Nutrition Sciences 2: 67-73, 2010.

Drugs

EvaluationDrugModalityDoseRoute
Subject L-alanine Unknown 6 g —